Key result
Embolic protection devices are in development to reduce stroke risk after TAVR.
Why the study?
Stroke is a major complication after transcatheter aortic valve replacement associated with high morbidity and mortality, prompting investigation into mechanisms and protective strategies.
Do embolic protection devices reduce the risk of stroke in patients undergoing transcatheter aortic valve replacement?
Do embolic protection devices reduce the risk of stroke in patients undergoing transcatheter aortic valve replacement?
This review highlights the mechanisms of stroke during TAVR and the potential role of embolic protection devices in mitigating this severe complication.
Stroke remains a major TAVR complication; review of mechanisms and embolic protection devices leaves open optimal prevention strategies.
Stroke has emerged as one of the most concerning complications following transcatheter aortic valve replacement (TAVR), associated with high morbidity and mortality. We discuss the potential mechanisms of stroke following TAVR, as well as the newly developed embolic protection devices aimed to reduce the risk of stroke.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (2014) studied this question. Embolic protection devices are being developed to reduce the risk of stroke, a complication associated with high morbidity and mortality following transcatheter aortic valve replacement.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: